Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network.

The ability of antibody induced by vaccination with recombinant gp160 (rgp160) to bind to native and recombinant human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins was measured. Thirty-three HIV-1-seronegative healthy adult volunteers were injected four times with 40 or 80 micrograms...

Full description

Saved in:
Bibliographic Details
Main Authors: Gorse, G J, Frey, S E, Newman, F K, Belshe, R B
Format: Artigo
Language:Inglês
Published: 1992
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC270486/
https://ncbi.nlm.nih.gov/pubmed/1400960
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items